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ABSTRACT
Purpose: A urodynam ic s tu d y  w as done to judge th e  capability  of la s e r  t r e a tm e n t  to  re lieve
b lad d e r outlet obstruction .
M ate ria ls  an d  M ethods: A dvanced urodynam ic stud ies w ith  p ressu re-flow  a n a ly s is  w ere  p e r ­
form ed before a n d  6 m on ths a fte r la se r tre a tm e n t u sing  3 d ifferent la se r  devices.
R esu lts: F o rty  p a tie n ts  show ed significant im provem ent in  all o b stru c tio n  p a ra m e te rs  (d e tru ­
sor p re ssu re  a t  m ax im um  flow ra te , u re th ra l resis tan ce  re la tion , th e o re tic a l c ro ss-sec tio n a l 
u re th ra l  a rea , m in im al d e tru so r p ressu re  and  lin ea r passive u re th ra l re s is ta n c e  re la tio n )  to ­
g e th e r  w ith  sign ifican t subjective im provem ent in  in te rn a tio n a l p ro s ta te  sym ptom  score. A fte r 
t re a tm e n t 82 to  92% of th e  p a tie n ts  could no longer be considered to  h av e  o b s tru c tio n . No 
difference in  outcom e am ong th e  devices used  w as found.
Conclusions: L ase r p ro sta tec tom y  is indeed  capable of reliev ing  b lad d e r o u tle t o b stru c tio n .
Key W ords: prostatic  hypertrophy, urodynam ics, prostatectom y, la se rs
For more than  7 decades prostates have been enucleated 
surgically and for almost 6 decades they have been resected 
endoscopic ally. Results have been impressive and increas­
ingly better, and the procedures are reasonably safe. In the 
1980s many alternatives to prostatectomy have surfaced, 
from a pharmacological approach to numerous procedural 
alternatives, for example balloon dilation, prostatic stents, 
hypertherm ia and thermotherapy. To date, none of these 
alternatives has reached subjective and objective results 
comparable to those noted after enucleation or resection of 
the prostate. Nevertheless, the morbidity of the operations is 
still greater th an  that for any of these alternatives.
Recently, a new instrum ental treatm ent modality for be­
nign pro static hyperplasia (BPH) became available, tha t is 
laser treatm ent of the prostate. The advantages of laser 
treatm ent are the minimal hospital stay, minimal bleeding, 
no fluid absorption, rapidity of treatm ent, technical simplic­
ity and chance of preservation of antegrade ejaculation.1 
Although present studies include few patients and the fol- 
lowup is short, the results after laser treatm ent are compa­
rable to those achieved after electroresection.2-7 To replace 
transu re th ra l resection of the prostate by laser prostatec­
tomy, the latter procedure should also be able to relieve 
outlet obstruction. In general patients are evaluated preop- 
eratively and postoperatively by means of symptom scores, 
uroflowmetry studies, post-void residual volume and pros­
ta te  size. These parameters are associated with obstructive 
voiding bu t not with the grade of obstruction and, therefore, 
they cannot be used to determine objectively whether outlet 
obstruction is relieved.8“10 To quantify the grade of bladder 
outlet obstruction, urodynamic investigation with pressure- 
flow analysis is considered the gold standard.11 We judged 
the obstruction relieving capabilities of laser treatm ent of the 
p rosta te .
PATIENTS AND METHODS
Since November 1992 we treated 125 patients with 3 dif­
ferent laser systems: the In tra  Sonix TULIP device, the Bard 
Urol ase fiber and the Heraeus Ultraline fiber. All patients
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underwent a screening program consisting of physical exam­
ination (including digital rectal examination), biochemistry 
(including prostate specific antigen [PSA]), and urine culture 
and sedimentation rate. T ransrectal u ltrasound of the pros­
tate was performed with planim etric m easurem ent of the 
prostate volume. Furthermore, renal u ltrasound was done to 
exclude hydronephrosis. All patients underw ent urethrocys­
toscopy to measure the prostate length, and to assess the size 
of the middle and lateral lobes. In case of a suspicious digital 
rectal examination, transrectal u ltrasound or an  elevated 
PSA level (greater than 10 ng./ml. or a PSA density of more 
than  0.15), prostate biopsies were obtained to exclude malig­
nancy. To evaluate the subjective param eters before and 
after the operation all patients had  to complete an  in terna­
tional prostate symptom score questionnaire and the symp­
tom score had to be at least 12. Objective param eters were 
evaluated by a free urinary flow ra te  using a Dantec Urodyn 
1000 uroflowmeter. The voided volume had to be a t least 150 
ml. The post-void residual volume, m easured by transabdom ­
inal ultrasonography, had to be less th an  350 ml. If patients 
fit these criteria, they were eligible for laser treatm ent. Uro­
dynamic investigations were performed w ith an 8F transu re­
thral lumen catheter with an  intravesical micro-tip pressure 
sensor. Abdominal pressure was recorded intrarectally  with 
an 8F micro-tip sensor catheter. Before cystometry the blad- m 
der was emptied through the lum en of the transureth ral 
catheter and then filled w ith sterile saline a t body tem pera­
ture and a filling speed of 50 ml. per m inute with the patient 
in the supine position. During the entire recording the sub- 
straction of vesical and abdominal pressure was examined 
every minute by asking the patient to cough during the filling 
phase. When standing up to void and when lying down after 
voiding, subs traction was again examined by coughing to 
ensure th a t the catheters were not dislocated. The pressure 
and flow data were recorded with commercially available 
equipment. The digitally stored data  were transla ted  to a 
urodynamic analysis computer program, developed a t  our 
department. Precise fitting of the automatically computed 
curves, with correction for pressure or flow artifacts, was 
done by hand. Patients with detrusor failure or urinary  re­
tention were excluded from this study.
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Different parameters were used to document obstruction, 
including the detrusor pressure a t maximum flow ra te  (grad­
ing according to the Abrams-Griffiths nomogram), intersec­
tion of quadratic urethral resistance relation with the pres­
sure axis of pressure flow (urethral resistance relation),9»10 
param eters calculated from the passive urethral resistance 
relation12-14 (minimal detrusor pressure with ongoing flow 
and theoretical cross-sectional area of the urethra) and linear 
passive urethral resistance relation (an approximation of the 
resistance relation by means of a straight line through min­
imal detrusor pressure and detrusor pressure at maximum 
flow rate  with grading according to the Schafer nomogram).14 
The majority of patients studied were classified as having 
urodynamic obstruction depending on the urodynamic pa­
ram eter used.
Before laser treatment, a suprapubic catheter was inserted 
for continuous flow through the endoscopic instrum ents. The 
day after laser treatm ent the patients were discharged from 
the hospital with the suprapubic catheter in situ. At the 
outpatient clinic the catheter was removed when voiding was 
satisfactory without a significant post-void residual volume. 
At 4 ,12  and 26 weeks the patients were evaluated with blood 
studies and urinalysis, uroflowmetry, and international pros­
ta te  symptom score, quality of life and sexual function ques­
tionnaires. At week 26 urodynamic investigations, transrec- 
ta l ultrasound of the prostate and cystoscopy were repeated. 
The Wilcoxon signed-rank tes t was used for statistical com­
parison of the preoperative and postoperative data.
RESULTS
To date 40 of the 125 patients treated  were evaluable for 
urodynamic analysis 6 months after laser prostatectomy. 
M ean patient age in this group was 63.8.years (range 51 to 
76). Mean values at baseline for patien t age, pro static size, 
peak urinary flow rates, post-void residual volume and inter­
national prostate symptom scores for the complete group are 
shown in table 1.
The changes in the parameters used are shown in table 2. 
All patients had an improvement in symptom scores. A mean 
international prostate symptom score at baseline of 21.7 ± 
6.7 (range 12 to 35) improved to 6.3 ±  4.6, w ith an individual 
improvement of 15.4 ± 8.1 a t 6 months. Mean peak urinary 
flow rate  improved from 8.0 ± 3.1 ml. per second (range 2.0 
to 14.0) preoperatively to 17.1 ± 5.9 ml. per second (range 3.9 
to 30) at 6 months. The mean individual improvement in 
peak urinary flow rate was 9.0 ± 6.2 ml. per second (range 
—3.1 to 20.0). The post-void residual volume decreased from 
a m ean 89.2 ± 102.3 ml. (range 0 to 350) at baseline to 18.2 
± 38.4 ml. (range 0 to 190) with a mean improvement of 71.0 
± 102.3 ml. (range —135 to 350) a t 6 months. All of these 
param eters demonstrated a statistically significant improve­
m ent (p <0.0001). Table 2 also shows the improvements in 
m ean values of the urodynamic param eters from the pres- 
sure-flow analysis at baseline and a t 6 months, all of which 
were statistically significant (p <0.0001),
For each different fiber the changes in the param eters are 
shown in table 3. No major differences in these param eters 
among the 3 different fibers were noted. For the U ltraline 
and Urolase fibers a statistical improvement was noted in all 
param eters. Although an absolute improvement was noted in 
all param eters, for the TULIP device there was no statistical
T able  1. Baseline characteristics o f 40 patien ts
Mean ± SD (range)
Age (yrs.) 63.8 ± 6.4 (51-76)
Prostate vol. (cm.3) 46.9 ± 15.9 (24-83)
Symptom score 21.7 H- 6.6 (12-35)
Maximum flow rate (mL/sec.) 8.0 ■f" 3.1 (2.0-14.0)
Post-void residual urine (ml.) 89.2 102.5 (0-350)
improvement in post-void residual volume, detrusor pressure 
a t maximum flow ra te  and m inim al detrusor pressure. The 
few patients in the TULIP group (7) should be considered.
Depending on w hat obstruction param eter was used, the 
incidence of preoperative urodynamic obstruction ranged 
from 65 to 90%. Post operatively 8 to 18% of th e  patien ts still 
can be considered as having obstruction (table 4). Figure 1 
shows the preoperative and postoperative values for detrusor 
pressure a t maximum flow rate  in  all patien ts using the 
nomogram of obstruction reported by Abrams and  Griffiths.11 
Figure 2 is a  visual representation of the urodynam ic param ­
eters used in  a pressure-flow plot before and after laser 
treatm ent.
DISCUSSION
In view of all the new available trea tm en t options, guide­
lines to standardize the assessm ent of BPH therapies are 
being developed, including among other th ings uroflowmetry 
(voided volume, maximum flow ra te  and post-void residual 
volume), blood studies and urinalysis (including PSA), pros­
ta te  size and weight, international prostate symptom score 
assessment, cystometry with sim ultaneous assessm ent of in­
travesical and intra-abdom inal pressure for determ ination of 
detrusor pressure and pressure-flow studies.15*16 To achieve 
results similar to those of tran su re th ra l resection of the 
prostate new treatm ent modalities should have the ability to 
relieve outlet obstruction. To document changes in the grade 
of obstruction a considerable num ber of param eters have 
been suggested. Although symptom scores, uroflowmetry 
studies, post-void residual volume and p rosta te  size are as­
sociated w ith outlet obstruction, there  appears to be no clear 
correlation with the grade of outlet obstruction. Sim ulta­
neous m easurem ents of intravesical pressure and flow rate  
during voiding enable one to distinguish objectively between 
obstruction or no obstruction. Consequently, advanced uro- 
dynamics (including pressure-flow analysis) are considered 
the best methods to document (changes in) the  grade of 
bladder outlet obstruction.
Since Abrams and Griffiths in 1979 first reported urody­
namic changes after surgical intervention for BPH ,11 there 
have been few other studies about th is subject.17-21 Studies 
concerning the evaluation of urodynamic changes in alterna­
tive BPH treatm ents are even more ra re .22”25 Available data 
suggest th a t urodynamic changes, i f  any, are m inim al. None 
of these studies has shown urodynam ic changes sim ilar to 
those after transu re th ra l resection of the prostate.
To date, to our knowledge only 2 studies have been pre­
sented using pressure-flow param eters for evaluation of 
treatm ent outcome after laser therapy. Bosch and Groen 
showed a decrease in detrusor pressure a t m axim um  flow 
ra te  and urethral resistance relation  after lase r therapy of 
the prostate using the TULIP device.26 D etrusor pressure a t 
maximum flow rate improved from 76 cm. w ater (range 26 to 
200) a t baseline to 39 cm. w ater (range 18 to 58) a t 3 months 
and urethral resistance relation decreased from 42 (range 22 
to 78) to 22 (range 11 to 35). In  our study detrusor pressure 
at maximum flow rate changed from 76 cm. w ater (range 38 
to 184) at baseline to 39 cm. w ater (range 15 to 74), and the 
u reth ral resistance relation improved from 49 (range 23 to 
130) to 19 (range 7 to 40) a t 6 months. We agree w ith the 
conclusion th a t TULIP laser treatm ent of the  prostate is 
urodynamic ally effective for BPH. A random ized laser versus 
transure th ra l resection of the prostate study by Gill and 
Kabalin showed an equal improvement in opening pressure 
and maximal detrusor pressure in both trea tm en t arm s.27 
They concluded th a t symptom scores and objective urody­
namic param eters dem onstrated laser prostatectom y to be 
effective treatm ent of bladder outflow obstruction secondary 
to BPH. Our results confirmed this conclusion.
No consensus has been reached to date on which param e-
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T a b le  2 . Urodynamic changes and symptom score improvement before and 6 months after laser prostatectom y in 40 patients
Symptom score 
Post-void residual urine (ml.)
Free flow maximum flow rate (ml./sec.)
Detrusor pressure at maximum flow rate (cm. water) 
U rethral resistance relation (cm. water)
Minimum detrusor pressure (cm. water)
Theoretical cross-sectional urethral area (mm.2) 
Linear p assiv e  urethral resistance relation
Mean ± SD
Before After IndividualImprovement
p Value
21.7 ± 6.7 6.3 ± 4.6 15.4 ± 8.1 0.0001
89.2 ± 102.5 18.2 ± 38.4 71.0 ± 102.3 0.0001
8.0 ± 3.1 17.1 ± 5.9 9.0 ± 6.3 0.0001
76.7 ± 34.3 39.3 ± 15.6 37.4 ± 29.8 0.0001
48.5 ± 22.4 18.7 ± 8.6 29.8 ± 22.6 0.0001
41.3 ± 23.9 17.3 ± 10.0 25.4 ± 23.1 0.0001
2.3 ± 1.1 7.5 ±4.1 5.2 ± 4.1 0.0001
3.6 ± 1.3 1.0 ± 1.0 2.6 ± 1.3 0.0001
T a b le  3 . M ean improvement (plus or minus standard deviation) in different parameters for each different fiber a t  baseline and at
6-month followup
TULIP (7 pts.) Urolase (19 pts.) Ultraline (14 pts.)
Before After Before After Before After
Symptom score 21.6 ± 8.0 7.6 ± 5.2 22.4 ± 6.0 6.0 ± 4.9 20.8 ± 7.3 6.1 ± 4.0
Free flow maximum flow rate (ml./sec.) 8.4 ± 2.2 18.4 ± 5.4 8.1 ± 3.3 16.3 ± 4.4 7.6 ± 3.3 17.5 ± 7.8
Post-void residual (ml.) 68 ± 70 22 ±40 * 80 ± 107 22 ± 49 111 ± 111 12 ± 18
Detrusor pressure at maximum flow rate (cm. water) 81 ± 48 46 ± 11 * 72 ± 31 40 ± 19 81 ±32 36 ± 12
U rethral resistance relation (cm. water) 53 ± 35 21 ± 8 46 ± 22 19 ± 9 50 ± 16 17 ± 8
Minimum detrusor pressure (cm. water) 46 ±38 20 ± 8 * 40 ± 22 19 ± 10 41 ± 19 14 ± 10
Theoretical cross-sectional urethral area (mm.2) 2.3 ± 1.3 6.9 ± 3.7 2.4 ± 1.0 7.3 ± 3.8 2.1 ± 1.1 8.1 ± 5.0
Linear p ass iv e  urethral resistance relation 3.7 ± 1.1 1.3 ± 0.8 3.5 ± 1.4 1.1 ± 1.2 3.8 ± 1.4 0.7 ± 0.9
* Not significant.
T ab le  4, D ifferen t criteria for grade o f obstruction and percentage 
of p a tie n ts  m a tch in g  these obstruction criteria before and 6 months 
after l a s e r  prostatectomy in complete group of 40 patients
Obstruction
No. (%)
Before After
Linear p ass iv e  urethral resistance relation:
More th a n  3 20 (50) 0 (0)
3 12 (30) 3 (8)
Less th a n  3 8(20) 37 (92)
Urethral resistance relation more than 29 36 (90) 4(10)
(cm. w ater)
Minimum detrusor pressure more than 29 26 (65) 7(18)
(cm. w ater)
Theoretical cross-sectional urethral area 33 (83) 4(10)
less th a n  3.0 (mm.2)
Detrusor pressure at maximum flow rate:
O bstructed 32 (80) 4(10)
Equivocal 8(20) 20 (50)
U nobstructed 0 (0) 16(40)
ters describe best the grade of obstruction. We evaluated the 
currently  m o s t used parameters for analysis.12“14*17’28 Bor­
der values u sed  to determine obstruction or no obstruction 
were l in e a r  passive urethral resistance relation of 3 or more, 
u re th ra l re s is tan ce  relation greater than  29 cm. water, min­
imal d e tru s o r  pressure greater than  29 cm. water, theoretical 
cross-sectional urethral area less than  3.0 mm.2 and detrusor 
pressure a t  m axim um  flow rate in the obstructive area on an 
A bram s-G riffiths nomogram. All of these parameters demon­
strated  a  statistically  significant improvement after laser 
tre a tm en t (tab le  3). Individually, few patients had less pro­
nounced im provem ent (figs. 3 to 7). Patients who were 
treated d u r in g  our learning curve (and might do worse) were 
also in c lu d ed  in this study.
The m a jo r ity  of our patients, based on different urody­
namic p a ra m e te rs , can be considered to have obstruction. It 
appears t h a t  laser treatm ent is capable of relieving urody­
namic ally  verified outlet obstruction. Although symptoms 
improved in  all patients, there was no clear correlation be­
tween th e  ex te n t of obstruction relieved and improvement in 
sym ptom s (figs. 3 to 7), which underlines again the discrep­
ancy b e tw e e n  objective and subjective parameters. I t is also 
known t h a t  patients with poor urine flow due to weak detru-
Qmax (ml/s)
•  baseline A 6 months
Fig. 1. Changes in detrusor pressure (P det) at maximum flow rate 
(■Qmax) before and 6 months after laser prostatectomy using 
Abrams-Griffiths nomogram11 for obstruction in all 40 patients.
sor contractions are those who respond worse to prostatecto- 
m y. 17.19,20 Our study shows th a t patients considered not to 
have obstruction also improved well, depending on which 
parameter was used to determine obstruction. Although the 
changes in obstructive param eters among these patients are 
less pronounced, which is to be expected because they have 
less to gain, the symptomatic improvement is considerable 
(figs. 3 to 7). Regarding laser treatm ent for BPH, studies in 
patients with less obstruction are mandatory to determine if 
laser is also capable of achieving substantial subjective and 
objective improvement. On the other hand, in  symptomatic 
patients with less obstruction other minimal invasive thera­
pies, for example medical treatm ent or transurethral micro­
wave thermo therapy, should be considered.
Comparing our study to the data  in the  literature on uro­
dynamic changes after transure th ra l resection of the pros­
tate, a similar improvement in u reth ral resistance relation is 
noted.17 The changes in detrusor pressure at maximum flow 
rate and in the curves of the pressure-flow plot after laser
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Fig. 2. Pressure-flow analysis before and 6 months after laser treatment. A, with urethral resistance relation (URA) curve. B, with passive 
urethral resistance relation (PURR) curve. C, with linear passive urethral resistance relation (L-PURR) curve and nomogram. Pdet, detrusor
pressure.
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Fig. 5. Correlation between improvement in symptom score 
(IPSS) and improvement in theoretical cross-sectional (Atheo) area of 
urethra in mm.2 for all 40 patients after laser treatment. L, patients 
who at baseline could not be considered to have obstruction.
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F ig . 4. Correlation between improvement in symptom score 
(IPSS) and improvement in minimal detrusor pressure with ongoing 
flow in cm. water (Pvoidmin) for all 40 patients after laser treatment. 
▲, patients who at baseline could not be considered to have obstruction.
140
1300«N 120X
E 110
too
+-■c 900
E 800> 70oL- 60cx
E 50
1X 40
E 30
O 20
10
+*O
T3 0CL - 10
-20
0
7
7
V
7 V
V
7
7
T V
Y
7
12 18 24
IPSS-improvement
obstructed not obstructed
V
7
30
Fig. 6. Correlation between improvement in symptom score 
(IPSS) and improvement in detrusor pressure (Pdet) at maximum 
flow rate (Qmax) in cm. water for all 40 patients after laser treat­
ment. A, patients who at baseline could not be considered to have 
obstruction.
prostatectom y (figs. 1 and 2) are similar to changes after 
tran su re th ra l resec tion  of the prostate.11*20
A  considerable num ber of studies concerning laser trea t­
m ent have b e e n  published, and many different fibers and 
energy settings h a v e  been used. To date no major differences 
in outcome h a v e  been reported using these different fibers. 
The general r e s u l ts  are the same and are comparable with 
resu lts after tra n s u re th ra l  resection of the prostate,2“7 In our 
study 3 d iffe ren t types of fibers were used. Although not 
random ized a n d  w ith  few patients in each group, no differ­
ences in the  e x te n t  of obstruction relieved among these 3 
fibers could b e  found (table 3). Laser energy seems to be 
capable of re lie v in g  outlet obstruction. The method of apply­
ing the energy ap p ears  to be secondary, and the treatm ent 
success depends largely on the preference and skills of the 
surgeon in u s in g  th e  various techniques. The different mor­
bidity ra tes  c a u s e d  by the various fibers and techniques 
should also be  considered. The long-term results may be 
different for e a c h  fiber or technique used and related to the
ability to c re a te  cavities.
T ra n su re th ra l resection of the prostate remains the gold 
standard  in  th e  trea tm en t of BPH to which all other new
treatm ent modalities should be compared. The objective of 
surgical treatm ent for prostatic obstruction must be to re­
lieve obstruction safely and effectively no matter w hat pro­
cedure or technique is used. The reasons for considering 
transurethral resection of the prostate as the most effective 
therapy are the excellent objective and subjective results 
reached and sustained for a  long period. To date none of the 
alternative treatm ents has accomplished similar or even bet­
ter results. With regard to laser prostatectomy, improve­
ments in symptoms and uroflowmetry are  impressive, and to 
a great extent comparable to the resu lts reached after tran s­
urethral resection of the prostate.2-6 However, long-term ef­
fects are not yet available and only speculations can be made 
about the final effect in the future.29 -30 A possibility to pre­
dict a long lasting effect m ight be the presence of a cavity on 
urethrocystoscopy or transrectal ultrasound of the prostate 
as a result of laser therapy. Moreover, the changes in  ob­
structive voiding to nonobstructive voiding measured in a 
pressure-flow analysis can contribute to a more accurate 
prediction.
We are aware th a t controversy still exists about w hether to 
perform a complete urodynamic evaluation routinely in  pa-
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Fig. 7. Correlation between improvement in symptom score 
{IPSS) and improvement in linear passive urethral resistance rela­
tion (L-PURRi approximation of resistance relation by means of 
straight line through minimal detrusor pressure and detrusor pres­
sure at maximum now rate) for all 40 patients after laser treatment. 
A, patients who at baseline could not be considered to have obstruc­
tion.
tients with BPH, and about the clinical relevance of precisely 
grading the obstruction. We believe th a t to date urodynamic 
investigations with pressure-flow analysis should first be 
considered as an essential research tool to evaluate best the 
outcome of alternative treatm ents for BPH. Moreover, we 
must determine the role of routine urodynamic investigation 
in the assessment of BPH in daily urological practice. More 
studies with different treatm ent modalities are needed to 
conclude if pressure-flow analysis can be used not only to dem­
onstrate the type and grade of obstruction but also to select 
patients for different (alternative) treatm ent options, Interest­
ingly, Tubaro et al showed that the treatm ent outcome of trans­
urethral microwave thermotherapy could be predicted from 
pressure-flow analysis, making patient selection possible.31 Fi­
nally, to solve the question of which fiber or technique used is 
superior in providing long lasting relief of obstruction, random­
ized studies with obligatory urodynamic and pressure-flow 
analysis evaluation of treatment outcome are necessary.
CONCLUSIONS
Urodynamic evaluation with pressure-flow analysis of 
treatment outcome after laser prostatectomy shows th a t la ­
ser is capable of relieving outflow obstruction comparable to 
results obtained with transurethral resection of the prostate. 
No apparent difference in ability to relieve obstruction was 
shown for the different fibers and techniques. To evaluate the 
ability to provide long lasting relief of obstruction for each 
different fiber, randomized studies w ith urodynamic evalua­
tion and pressure-flow analyses are mandatory.
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